Stock listing
NYSE:NVRO Nevro Corp Stock
Follow Nevro Corp into a list and get an email when it puts out news.
Last close · NYSE:NVRO
$5.84 USD
Close on Apr 2, 2025 · No longer trades
- Lowest – highest close
- $3.29 – $184.34 USDSince Nov 6, 2014 · lowest Jan 10, 2025 · highest Dec 23, 2020
Delisted NYSE:NVRO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NYSE:NVRO
- Asset type
- Stock
- Exchange
- NYSE
- Currency
- USD
Nevro Corp on 6ix
- Calls
- 17 calls with a replay · 17 with a transcript · latest Nov 11, 2024
- Decks
- 2 decks · latest Nov 14, 2024
Events
| Call | When | Status |
|---|---|---|
| Nevro (NVRO) Q3 2024 Earnings Call | Mon, Nov 11, 2024 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q2 2024 Earnings Call | Tue, Aug 06, 2024 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q1 2024 Earnings Call | Tue, May 07, 2024 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q4 2023 Earnings Call | Wed, Feb 21, 2024 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q3 2023 Earnings Call | Wed, Nov 01, 2023 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q2 2023 Earnings Call | Tue, Aug 01, 2023 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q1 2023 Earnings Call | Wed, Apr 26, 2023 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q4 2022 Earnings Call | Thu, Feb 16, 2023 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q3 2022 Earnings Call | Wed, Nov 02, 2022 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q2 2022 Earnings Call | Wed, Aug 03, 2022 · 4:30 PM ET | Replay |
All 17 calls
| Call | When | Status |
|---|---|---|
| Nevro (NVRO) Q1 2022 Earnings Call | Wed, May 04, 2022 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q4 2021 Earnings Call | Wed, Feb 23, 2022 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q3 2021 Earnings Call | Mon, Nov 08, 2021 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q2 2021 Earnings Call | Wed, Aug 04, 2021 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q1 2021 Earnings Call | Wed, May 05, 2021 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q4 2020 Earnings Call | Wed, Feb 24, 2021 · 4:30 PM ET | Replay |
| Nevro (NVRO) Q3 2020 Earnings Call | Thu, Nov 05, 2020 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2024 Earnings Presentation | Earnings | 15 slides | Nov 14, 2024 |
| J.P. Morgan 37th Annual Healthcare Conference (January 2019) | Conference | 30 slides | Jan 7, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Karen N. Prange Other companies: Outset Medical, Inc. (Director · Since at least Jan 9, 2026); Embecta Corp. (Director · Since at least Apr 1, 2022); AtriCure, Inc. (Director · Since at least Dec 4, 2019); Cantel Medical Corp (Director · Oct 28, 2019 – Jun 2, 2021 · Past); Henry Schein, Inc. (EVP&CEO Gl.AH.Med.Den.Sur.Grp · May 17, 2016 – Mar 2, 2018 · Past) | Director · Dec 17, 2019 – Apr 3, 2025 · Past |
| Elizabeth Weatherman Other companies: Royalty Pharma plc (Director · Since at least Jul 17, 2025); Insulet Corporation (Director · Since at least May 22, 2024); Silk Road Medical Inc (Director · Jun 18, 2024 – Sep 17, 2024 · Past); Vapotherm Inc (Director · Jan 1, 2024 – Sep 20, 2024 · Past) | Director · Sep 30, 2023 – Apr 3, 2025 · Past |
| Lisa D Earnhardt Other companies: Abbott Laboratories (EVP AND GROUP PRESIDENT · Since at least Jun 10, 2019); Intersect ENT Inc (Director · Oct 16, 2017 – Jul 24, 2019 · Past) | Director · May 21, 2018 – May 21, 2018 · Past |
| Susan E Siegel Other companies: Align Technology, Inc. (Director · Since at least May 21, 2025); Illumina, Inc. (Director · Since at least May 21, 2025) | Director · Apr 3, 2025 – Apr 3, 2025 · Past |
| Wilfred E Jaeger Other companies: Neuronetics, Inc. (Director · Jun 27, 2018 – May 25, 2023 · Past); Concert Pharmaceuticals Inc (Director · Jun 14, 2018 – Mar 6, 2023 · Past) | Director · Feb 27, 2018 – May 21, 2020 · Past |
| James Alecxih Other companies: TriSalus Life Sciences, Inc. (President, Device Technology · Aug 10, 2023 – Aug 10, 2023 · Past) | Vice President, Sales · Dec 12, 2017 – Dec 12, 2017 · Past |
| Kashif Rashid Other companies: Sight Sciences, Inc. (Chief Legal Officer · Since at least Aug 10, 2026) | SVP, Corp Dev and CLO · Dec 18, 2017 – Apr 3, 2025 · Past |
| Niamh Louise Pellegrini Other companies: Acutus Medical Inc. (Director · Aug 10, 2021 – Jun 15, 2023 · Past) | Chief Commercial Officer · Jul 15, 2019 – May 28, 2023 · Past |
| Rami Elghandour Other companies: Arcellx Inc (SEE REMARKS, Director · Since at least Feb 3, 2022) | President & CEO, Director · Apr 1, 2016 – Jan 3, 2019 · Past |
| Balakrishnan Shankar | VP, Operations · Nov 5, 2014 – Jan 13, 2015 · Past |
All 16 people
| Person | Seat |
|---|---|
| Christofer Christoforou | SVP, Chief Operating Officer · Aug 17, 2016 – Apr 3, 2025 · Past |
| Michael F Demane | Director · Sep 30, 2023 – Apr 3, 2025 · Past |
| Nathan B Pliam | Director · Nov 5, 2014 – Jun 8, 2015 · Past |
| Patrick Schmitz | Vice President, Operations · Mar 14, 2016 – Feb 28, 2020 · Past |
| Richard B Carter | Chief Accounting Officer · Sep 7, 2022 – Mar 7, 2024 · Past |
| Roderick H MacLeod | SVP, Chief Financial Officer · Jun 15, 2020 – Apr 3, 2025 · Past |
Log in to ask 6ix AI your own questions about Nevro Corp.